FDA Woman Vigra Flibanserin Anti Depression Drug Treating Sex Desire Disorder

Place of Origin CHINA
Brand Name XRD
Certification GMP
Model Number 167933-07-5
Minimum Order Quantity negotiable
Price Inquiry for Negotiable
Packaging Details 1-2 Kg / Aluminum Foil Bag, 25kg/ Drum, as Require
Delivery Time 1-2days after payment received
Payment Terms T/T, Western Union,Bitcoin
Supply Ability 100kg/year

Contact me for free samples and coupons.

Whatsapp:0086 18588475571

Wechat: 0086 18588475571

Skype: sales10@aixton.com

If you have any concern, we provide 24-hour online help.

Product Details
Cas No. 167933-07-5 Product Name Flibanserin
Usage Pharmaceutical Raw Material Appearance White Powder
Assay 99% Flibanserin Grade Pharmaceutical Grade
Storage Cool Dried Storage Application Pharmaceutical Raw Intermediates
High Light

pharmaceutical grade raw materials


sleeping pill eszopiclone

Leave a Message
Product Description

FDA Woman Vigra Flibanserin Raw Powder Treating Sex Desire Disorder



Quick Detail:
Model NO. 167933-07-5
Customized Customized
Suitable for Adult
Purity >99%
Flibanserin Alias Flibanserin
Flibanserin Assay >99%
Flibanserin Molecular Formula C20h21f3n4o
Flibanserin Function for Female Sex Desire
Flibanserin Markes Global
Transport Package Disguised Package or as Required
Origin China
Powder Yes
Certification GMP, HSE, ISO 9001, USP, BP
State Solid
Flibanserin Name Flibanserin
Flibanserin CAS 167933-07-5
Flibanserin Appearance White Crystalline Powder
Flibanserin MOQ 10 Grams
Flibanserin Standard SGS, GMP, ISO9001
Specification Raw Powders
HS Code 0601101000
Port Hong Kong, Hong Kong
Production Capacity 50t
Payment Terms L/C, T/T, D/P, Western Union, Money Gram, Bitcoin; Bank Transfer

Flibanserin (INN, USAN), sold under the trade name Addyi, is a medication approved for the treatment of pre-menopausal women with hypoactive sex desire disorder (HSDD).The medication increases the number of satisfying sex events per month by about one half to one over placebo from a starting point of about two to three.

HSDD was recognized as a distinct sex function disorder for more than 30 years, but was removed from the Diagnostic and Statistical Manual of Mental Disorders in 2013, and replaced with a new diagnosis called female sex interest/arousal disorder (FSIAD).

A new drug designed to boost sex desire in women is controversial for some and eagerly awaited by others, but it's hit a potentially serious snag. The drug didn't boost women's desire any more than a placebo in two clinical trials. The Food and Drug Administration posted the clinical trial results on its website today in advance of a committee meeting on Friday, when a panel of experts will vote whether or not to recommend approval of the drug called flibanserin. (The FDA usually follows the recommendations of its expert panels.) Although there was a slight increase in the number of sexl satisfying events flibanserin users had each month, the FDA staff who reviewed the results said so called response rate isn't " particularly compelling."

It's called the "little pink pill," a tiny tablet that could have a huge impact on treating female sex dysfunction. If it's approved, it would become the first drug of its kind on the market.


FDA Woman Vigra Flibanserin Anti Depression Drug Treating Sex Desire Disorder 0

FDA Woman Vigra Flibanserin Raw Powder Treating Sex Desire Disorder